Management of <i>EGFR</i>-Variant and <i>ALK</i>-Positive Non–Small Cell Lung Cancer Brain Metastasis
This clinical evidence synopsis summarizes the results of 3 multi-institutional cohort studies that compare tyrosine kinase inhibitors with or without stereotactic radiosurgery in patients with non–small cell lung cancer with brain metastases.
Authors
- Helena A. Yu (ORCID: https://orcid.org/0000-0002-0377-9510)
- Luke Pike (ORCID: https://orcid.org/0000-0001-9622-7442)
- Chad G. Rusthoven (ORCID: https://orcid.org/0000-0002-6978-2077)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1001/jamaoncol.2025.0188
- Citations
- 2
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04